Machine learning analysis of RNA-Seq data to de-risk repositioning of existing FDA-approved drugs

October 30, 2018 Leave a comment 1,643 Views

AMPEL BioSolutions announced proof-of-principle for a multi-pronged approach to rank small molecules and biologics for safe, effective treatment of patients with Systemic Lupus Erythematosus (SLE) and...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Stelara

Machine learning analysis of RNA-Seq data to de-risk repositioning of existing FDA-approved drugs

NIH scientists build a cellular blueprint of multiple sclerosis lesions

RNA sequencing provides insights into the cellular and molecular changes in male infertility

The MAQC Society announces publication of a collection of next-gen sequencing best practice articles

New research provides useful genetic resource on farm-raised kuruma shrimp

Rutgers neurologist explores link between COVID and ‘Brain Fog,’ dementia with MRI and RNA sequencing

Upcoming Webinar – Impact of SARS-CoV-2 Infection on Host Gene Expression Across Multiple Tissues at Single Cell Resolution

Tissue heterogeneity as a widespread phenomenon in publicly available gene expression datasets